NOMAD POWER SOLUTIONS, INC. Stock-Based Compensation
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Stock-Based Compensation of $704.41 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $622.23K, a 132.18% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $82.18K, a 17.61% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $268.00K.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $99.74K.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $1.39M, a 231.80% increase from fiscal 2024.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $418.42K.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $1.55M, a 40.51% decline from fiscal 2021.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $2.60M, a 107.69% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $622.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $704.41K 10-Q · filed 2026-08-14 | |||||
| 2026-03-31 | $82.18K 10-Q · filed 2026-05-14 | ||||||
| 2025-12-31 | $1.39M 10-K · filed 2026-03-31 | ||||||
| 2025-06-30 | $268.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $367.74K 10-Q · filed 2026-08-14 | |||||
| 2025-03-31 | $99.74K 10-Q · filed 2026-05-14 | ||||||
| 2024-12-31 | $418.42K 10-K · filed 2026-03-31 | ||||||
| 2023-09-30 | $112.11K 10-Q · filed 2023-11-09 | $392.17K derived: sum of 2 quarters · filed 2023-11-09 | $669.15K 10-Q · filed 2023-11-09 | $1.05M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2023-06-30 | $280.06K 10-Q · filed 2023-08-09 | $557.04K 10-Q · filed 2023-08-09 | $942.43K derived: sum of 3 quarters · filed 2023-08-09 | $1.34M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2023-03-31 | $276.98K 10-Q · filed 2023-05-10 | $662.37K derived: sum of 2 quarters · filed 2023-05-10 | $1.06M derived: sum of 3 quarters · filed 2023-11-09 | $1.48M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-12-31 | $385.39K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $782.27K derived: sum of 2 quarters · filed 2023-11-09 | $1.21M derived: sum of 3 quarters · filed 2023-11-09 | $1.55M 10-K · filed 2023-03-29 | |||
| 2022-09-30 | $396.88K 10-Q · filed 2023-11-09 | $820.98K derived: sum of 2 quarters · filed 2023-11-09 | $1.16M 10-Q · filed 2023-11-09 | $1.91M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $424.09K 10-Q · filed 2023-08-09 | $763.77K 10-Q · filed 2023-08-09 | $1.51M derived: sum of 3 quarters · filed 2023-08-09 | $1.86M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $339.67K 10-Q · filed 2023-05-10 | $1.08M derived: sum of 2 quarters · filed 2023-05-10 | $1.43M derived: sum of 3 quarters · filed 2023-05-10 | $2.28M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $744.86K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.09M derived: sum of 2 quarters · filed 2023-03-29 | $1.94M derived: sum of 3 quarters · filed 2023-03-29 | $2.60M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $347.22K 10-Q · filed 2022-11-08 | $1.20M derived: sum of 2 quarters · filed 2022-11-08 | $1.85M 10-Q · filed 2022-11-08 | $2.04M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $850.80K 10-Q · filed 2022-08-10 | $1.51M 10-Q · filed 2022-08-10 | $1.69M derived: sum of 3 quarters · filed 2022-08-10 | $2.76M derived: sum of 4 quarters · filed 2022-08-10 | |||
| 2021-03-31 | $656.03K 10-Q · filed 2022-05-11 | $842.63K derived: sum of 2 quarters · filed 2022-05-11 | $1.91M derived: sum of 3 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $186.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $1.25M derived: sum of 2 quarters · filed 2022-03-21 | $1.25M 10-K · filed 2022-03-21 | ||||
| 2020-09-30 | $1.06M 10-Q · filed 2021-11-10 | $1.06M 10-Q · filed 2021-11-10 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $439.05K derived: sum of 2 quarters · filed 2021-03-26 | $735.72K derived: sum of 3 quarters · filed 2021-03-26 | $748.65K 10-K · filed 2021-03-26 | |||
| 2019-09-30 | $439.05K 10-Q · filed 2020-11-10 | $735.72K derived: sum of 2 quarters · filed 2020-11-10 | $748.65K 10-Q · filed 2020-11-10 | $761.88K derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $296.67K 10-Q · filed 2020-08-10 | $309.60K 10-Q · filed 2020-08-10 | $322.82K derived: sum of 3 quarters · filed 2020-08-10 | $1.10M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $12.94K 10-Q · filed 2020-05-11 | $26.16K derived: sum of 2 quarters · filed 2020-05-11 | $798.55K derived: sum of 3 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $13.22K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $785.61K derived: sum of 2 quarters · filed 2020-03-25 | $785.61K 10-K · filed 2020-03-25 | ||||
| 2018-09-30 | $772.39K 10-Q · filed 2019-11-08 | $772.39K 10-Q · filed 2019-11-08 | |||||
| 2016-06-30 | $178.69K 10-Q · filed 2016-08-10 | $148.32K 10-Q · filed 2016-08-10 | $271.63K derived: sum of 3 quarters · filed 2016-08-10 | $529.38K derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2016-03-31 | -$30.37K 10-Q · filed 2016-05-06 | $92.93K derived: sum of 2 quarters · filed 2016-05-06 | $350.69K derived: sum of 3 quarters · filed 2016-05-06 | $435.33K derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2015-12-31 | $123.30K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $381.06K derived: sum of 2 quarters · filed 2016-03-28 | $465.70K derived: sum of 3 quarters · filed 2016-08-10 | $549.70K 10-K · filed 2016-03-28 | |||
| 2015-09-30 | $257.76K 10-Q · filed 2015-11-10 | $342.40K derived: sum of 2 quarters · filed 2016-08-10 | $426.40K 10-Q · filed 2015-11-10 | $693.06K derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2015-06-30 | $84.64K 10-Q · filed 2016-08-10 | $168.64K 10-Q · filed 2016-08-10 | $435.30K derived: sum of 3 quarters · filed 2016-08-10 | $555.52K derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2015-03-31 | $83.99K 10-Q · filed 2016-05-06 | $350.66K derived: sum of 2 quarters · filed 2016-05-06 | $470.87K derived: sum of 3 quarters · filed 2016-05-06 | $647.00K derived: sum of 4 quarters · filed 2016-05-06 | |||
| 2014-12-31 | $266.67K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $386.88K derived: sum of 2 quarters · filed 2016-03-28 | $563.01K derived: sum of 3 quarters · filed 2016-03-28 | $946.17K 10-K · filed 2016-03-28 | $946.17K 10-K · filed 2015-03-27 | ||
| 2014-09-30 | $120.21K 10-Q · filed 2015-11-10 | $296.34K derived: sum of 2 quarters · filed 2015-11-10 | $679.51K 10-Q · filed 2015-11-10 | $679.51K 10-Q · filed 2014-11-12 | |||
| 2014-06-30 | $176.13K 10-Q · filed 2015-08-07 | $559.30K 10-Q · filed 2015-08-07 | $559.29K 10-Q · filed 2014-08-08 | ||||
| 2014-03-31 | $383.16K 10-Q · filed 2015-05-13 | ||||||
| 2013-12-31 | $119.25K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |